At least one new ketamine-for-OUD clinical trial registration or published protocol appears within 10 weeks, building on today's OUD signal.

Predicted 2026-09-01 · Resolves 2026-11-15 · clinical · Global

62%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

Within ten weeks — by November 15, 2026 — at least one new clinical trial testing ketamine as a treatment for opioid addiction will be officially registered on the US government's trial database (ClinicalTrials.gov), or a research team will publish a detailed plan for such a study. Ketamine is already used in hospitals and clinics, so the infrastructure to run these studies exists. The opioid crisis also means there's real government money chasing new treatments.

Resolution rule: YES if a new interventional trial studying ketamine for opioid use disorder is first-registered on clinicaltrials.gov between 2026-09-01 and 2026-11-15, OR a new protocol paper on the topic is published/indexed in PubMed in that window. Checked via clinicaltrials.gov and PubMed on 2026-11-15.

The Ketamine-for-OUD signal reflects genuine research momentum. Opioid crisis funding plus existing ketamine infrastructure make OUD the next expansion frontier.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →